# 2026-13608: Feds Eye Schedule I for Tiny Kratom Ingredient

2026-13608, Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information, is a Federal Register notice from Health and Human Services Department published 2026-07-06, effective Submit either electronic or written comments, data, or information by July 31, 2026.; PRIA reads it as touching household money (as of 2026-07-13).

- Canonical: https://policyrisk.com/federal-register/2026-13608
- As of: 2026-07-13
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-13608
- Title: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information
- Type: Notice
- Agencies: Health and Human Services Department
- Citation: 91 FR 41049
- Published: 2026-07-06
- Effective: Submit either electronic or written comments, data, or information by July 31, 2026.
- Comments close: 2026-07-31
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-13

## In one line

Feds Eye Schedule I for Tiny Kratom Ingredient

## Summary

The government is planning to temporarily put 7-hydroxymitragynine, a chemical found in kratom, into the strictest drug category (Schedule I) if it’s above a tiny amount. This affects anyone making, selling, or using kratom products with higher levels of this chemical. People have until July 31, 2026, to share their thoughts, and this move could change how kratom products are handled and sold.

## Abstract

The Office of the Assistant Secretary for Health (OASH or we) is opening a public docket to solicit input and comments on a proposed threshold for 7-hydroxymitragynine (7-OH) scheduling under the Controlled Substances Act. Public comments submitted to this docket will be provided by the Secretary for Health and Human Services for consideration by the Attorney General.

## Effects PRIA read

- Temporary Schedule I Placement for 7‑OH: cost, high. The Department of Health and Human Services is supporting a DEA temporary order to place 7‑hydroxymitragynine (7‑OH) above a specified threshold into Schedule I of the Controlled Substances Act for up to two years. If the temporary order is issued, products or materials that meet the threshold woul…
- Numeric Thresholds That Trigger Controls: cost, medium. DEA's specified threshold would treat as Schedule I: (A) any Mitragyna speciosa (kratom) botanical material containing more than 0.050% 7‑hydroxymitragynine (7‑OH) on a dry weight basis; or (B) alternative articles (including synthetic products or processed extracts, concentrates, edibles, or pills…
- Public Comment Invitation on Threshold and Measures: benefit, low. OASH has opened a public docket (HHS‑OASH‑2026‑0232) and requests data and comments by July 31, 2026 on whether the identified 7‑OH threshold constitutes an imminent hazard to public safety and on possible alternative measurement expressions. Submitted comments will be provided to the Attorney Gene…

## Related documents

- [2026-22812](https://policyrisk.com/federal-register/2026-22812): Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care, 2026-11-10
- [2026-22792](https://policyrisk.com/federal-register/2026-22792): Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program, 2026-11-09
- [2026-22750](https://policyrisk.com/federal-register/2026-22750): Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the E…, 2026-11-09
- [2026-22743](https://policyrisk.com/federal-register/2026-22743): Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage…, 2026-11-09
- [2026-22739](https://policyrisk.com/federal-register/2026-22739): Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; i…, 2026-11-06
- [2026-22381](https://policyrisk.com/federal-register/2026-22381): Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, 2026-11-03

## Sources
- [2026-13608 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/06/2026-13608/temporary-placement-of-7-hydroxymitragynine-above-a-specified-threshold-in-schedule-i-request-for)
- [2026-13608 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-06/pdf/2026-13608.pdf)

## Related
- [Previous: 2026-13607, Certain Corrosion-Resistant Steel Products From the People's Republic of China:…](https://policyrisk.com/federal-register/2026-13607)
- [Next: 2026-13610, Diamond Sawblades and Parts Thereof From China; Scheduling of an Expedited Five…](https://policyrisk.com/federal-register/2026-13610)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-13608 (as of 2026-07-13).
